Myeloid Neoplasm

18 registered clinical trials studyying Myeloid Neoplasm — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukem NCT07094750	Fred Hutchinson Cancer Center	N/A
Recruiting	Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life NCT06710418	University of Washington	N/A
Recruiting	A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabi NCT05796570	Franziska Wachter	Phase 2
Active Not Recruiting	Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms NCT05656248	St. Jude Children's Research Hospital	Phase 2
Recruiting	Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms NCT04797767	University of Washington	Phase 1 / Phase 2
Recruiting	A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms NCT04981821	University of Rochester	N/A
Recruiting	Two Step Haplo With Radiation Conditioning NCT05031897	Thomas Jefferson University	Phase 2
Terminated	CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measur NCT04526288	Fred Hutchinson Cancer Center	Phase 2
Terminated	Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia NCT04196010	University of Washington	Phase 1
Active Not Recruiting	CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in NCT04195945	Fred Hutchinson Cancer Center	Phase 2
Recruiting	The Myeloid Neoplasms Biology and Outcome Project NCT05074316	University Hospital Heidelberg	—
Active Not Recruiting	Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT03862157	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With New NCT03012672	University of Washington	Phase 2
Completed	Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grad NCT02756572	University of Washington	Phase 2
Completed	Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition NCT01817075	Children's Oncology Group	Phase 3
Active Not Recruiting	Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01371981	National Cancer Institute (NCI)	Phase 3
Completed	Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemother NCT01307579	Children's Oncology Group	Phase 3
Completed	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia NCT00866918	Children's Oncology Group	Phase 3